Abstract
To the Editor: Contact sensitization is a requisite for the development of allergic contact dermatitis. This process may occur more readily on an impaired skin barrier, particularly for weak sensitizers.1 Therefore, patients with eczematous dermatoses treated with a topical corticosteroid (TC) can experience worsening due to the very medication meant to help. In these situations, the selection of an appropriate TC can be challenging. Patch testing data suggest that sensitization to inactive ingredients in prescription TCs occurs more frequently than to the active ones,2,3 and the use of specific inactive ingredients can vary with the TC active ingredient, vehicle, and even manufacturer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
